Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches

Immunotherapy is extensively investigated for almost all types of hematologic tumors, from preleukemic to relapse/refractory malignancies. Due to the emergence of technologies for target cell characterization, antibody design and manufacturing, as well as genome editing, immunotherapies including ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Ji-Yoon, Seo, Huiyun, Lee, Jungwoon, Jung, Haiyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663624/
https://www.ncbi.nlm.nih.gov/pubmed/33121189
http://dx.doi.org/10.3390/ijms21218000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663624/
https://www.ncbi.nlm.nih.gov/pubmed/33121189
http://dx.doi.org/10.3390/ijms21218000

Ejemplares similares